Effects of Rhythmic Auditory Stimulation on Movements in Individuals at Risk for Psychotic Onset and Schizophrenia Patients
NCT04553835 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2022-05-23
Summary
The purpose of this research is to examine effects of movement training with the aid of rhythmic auditory stimulation (RAS) on reducing severity of dyskinesia and bradykinesia in at-risk individuals and schizophrenia patients. The investigators hypothesize that training with the aid of RAS reduced severity of bradykinesia and dyskinesia in at-risk individuals as well as in schizophrenia patients.
Conditions
- Schizophrenia
- Psychosis
- Parkinsonism
- Dyskinesias
Interventions
- BEHAVIORAL
-
Rhythmic auditory stimulation (RAS) for schizophrenia patients
A mobile application, "metronome beats" developed by Stonekick Limited, will be used to give RAS when the participant executes the movement. Before intervention, the participant is required to execute the movement task without the aid of RAS as quickly as possible for 30 seconds, so that we obtain his/her baseline movement tempo (beats per minute). For each 40-minute training session in the first training week, three RAS tempi will be provided for the first, second, and last 10 minutes with a five-minute break in between: normal (100% of the baseline tempo), quick (105% of the baseline tempo), and fast (110% of the baseline tempo). With each training week, the three RAS tempi will be increased by 5%. Schizophrenia patients in the experimental group will undergo upper limb movement training with the aid of RAS. The intervention protocol will last for 3 weeks on the weekday basis (a total of 15 sessions) with one session (40 minutes) per weekday.
- BEHAVIORAL
-
No RAS for schizophrenia patients
The training protocol will be the same as that used in the experimental group except the lack of RAS during execution of the movement task.
- BEHAVIORAL
-
RAS for at-risk individuals
A mobile application, "metronome beats" developed by Stonekick Limited, will be used to give RAS when the participant executes the movement. Before intervention, the participant is required to execute the movement task without the aid of RAS as quickly as possible for 30 seconds, so that we obtain his/her baseline movement tempo (beats per minute). For each 40-minute training session in the first training week, three RAS tempi will be provided for the first, second, and last 10 minutes with a five-minute break in between: normal (100% of the baseline tempo), quick (105% of the baseline tempo), and fast (110% of the baseline tempo). With each training week, the three RAS tempi will be increased by 5%. At-risk individuals in the experimental group will undergo upper limb movement training with the aid of RAS. The intervention protocol will last for 3 weeks on daily basis (a total of 21 sessions), with one training session (40 minutes) per day.
- BEHAVIORAL
-
No RAS for at-risk individuals
The training protocol will be the same as that used in the experimental group except the lack of RAS during execution of the movement task.
Sponsors & Collaborators
-
Dr WANG Shumei
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 13 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-08-31
- Primary Completion
- 2022-12-31
- Completion
- 2022-12-31
Countries
- Hong Kong
Study Locations
More Related Trials
-
The Effects of Simultaneous Training of Walking and Cognitive Tasks on Cognitive Functions of People With Schizophrenia
NCT04143308 ·Status: COMPLETED ·Phase: NA
-
The Effects of Auditory Stimulation During Sleep on Brain Networks in Schizophrenia
NCT06386588 ·Status: RECRUITING ·Phase: NA
-
Transcranial Alternating Current Stimulation (tACS) for Auditory Hallucinations
NCT05159336 ·Status: UNKNOWN ·Phase: NA
-
Restoring Spindle and Thalamocortical Efficiency in Early-Course Schizophrenia Patients Using Auditory Stimulation
NCT05956951 ·Status: RECRUITING ·Phase: NA
-
Efficacy of tACS for Treatment of Auditory Hallucinations in Refractory Schizophrenia
NCT05282329 ·Status: COMPLETED ·Phase: NA
-
Remediation of Auditory Recognition in Schizophrenia With tDCS
NCT02869334 ·Status: COMPLETED ·Phase: NA
-
Changes in Auditory Verbal Hallucination During Atypical Antipsychotic Treatment of Patients With Schizophrenia
NCT00328952 ·Status: COMPLETED
-
The Hi-tACS on Cognitive Function in Patients With Schizophrenia: a Pilot Study
NCT06231732 ·Status: RECRUITING ·Phase: NA
-
Improving Cognition Via Exercise in Schizophrenia
NCT03270098 ·Status: COMPLETED ·Phase: NA
-
tACS to Improve Negative Symptoms & Cognition in Long-term Hospitalized Schizophrenia Patients.
NCT07074704 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Real-time fMRI Neurofeedback in Patients With Schizophrenia and Auditory Hallucinations
NCT05299749 ·Status: RECRUITING ·Phase: NA
-
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
NCT04411979 ·Status: COMPLETED ·Phase: NA
-
Linear and Non-linear Analysis of EEG Changes in Schizophrenia After Atypical Antipsychotics Medication
NCT00698295 ·Status: UNKNOWN
-
Auditory Control Enhancement (ACE) in Schizophrenia
NCT06155695 ·Status: TERMINATED ·Phase: NA
-
Combined Exercise and PMS: Impact on Biopsychosocial Function in Older Adults With Schizophrenia
NCT07194460 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effects of a Psycho-corporal Training on Postural and Cognitive Dual-task Performances in Patients With Schizophrenia
NCT03280810 ·Status: COMPLETED ·Phase: NA
-
Improving Cognition in Schizophrenia Using Non-invasive Brain Stimulation
NCT04184830 ·Status: COMPLETED ·Phase: NA
-
Developing Dual-channel Transcranial Alternating Current Stimulations Targeting Negative Symptoms in Schizophrenia
NCT04859504 ·Status: COMPLETED ·Phase: NA
-
Tandospirone Combined With Atypical Antipsychotic Drugs in Schizophrenia
NCT02040883 ·Status: UNKNOWN ·Phase: PHASE4
-
Rt-fMRI Neurofeedback and AH in Schizophrenia
NCT03504579 ·Status: COMPLETED ·Phase: NA
-
Paired Associative Stimulation in the Dorsolateral Prefrontal Cortex in Patients With Schizophrenia
NCT01545999 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evoked Responses as Pharmacodynamic Biomarkers in Healthy and Schizophrenic Participants (MK-4334-007)
NCT05136690 ·Status: COMPLETED ·Phase: PHASE1
-
Theta tACS During Working Memory Training: A Pilot Study of the Effects on Negative Symptoms of Schizophrenia
NCT04545294 ·Status: COMPLETED ·Phase: NA
-
Brain Stimulation, Clinical Symptoms and Cognition
NCT05053451 ·Status: COMPLETED ·Phase: NA
-
The Influence of Aerobic Exercise on Cognitive Functioning in Schizophrenia.
NCT01897064 ·Status: COMPLETED ·Phase: NA